Chang Gung Memorial Hospital, Linkou
Taoyuan, Taiwan, 333
NCT Number: NCT06286332
The objective of this study is to assess the efficacy of employing music therapy in alleviating fatigue and medical laboratory values among patients with acute myeloid leukemia.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Taoyuan, Taiwan, 333
The researchers will explain the study objectives and methods, obtain informed consent, and have participants sign the consent form before commencing the study. Participants are randomly assigned to Group A and Group B. Participants in Group A undergo 30 minutes of self-selected music playback every day in addition to receiving standard therapy, while participants in Group B only receive standard therapy. The entire study duration spans 21 days.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
30 minutes of self-selected music playback every day.
Time frame: Day 21.
The TFRS is a validated, self-reported instrument assessing average fatigue intensity. It comprises a total of 37 items, with each item rated on a scale of 1 to 10. The total score is calculated by summing all 37 items, resulting in a range of 37 to 370. Higher scores indicate a greater level of fatigue intensity.
Time frame: Day 21.
The NRS-11 is validated, self-reported instrument assessing average fatigue intensity. NRS-11 scores range from 0 (no fatigue) to 10 (worst possible fatigue).
Time frame: Day 21.
Absolute neutrophil count (ANC) was assessed through blood samples collected on the 21st day.
Time frame: Day 21.
Hemoglobin levels were assessed through blood samples collected on the 21st day.
Time frame: Day 21.
Albumin levels were assessed through blood samples collected on the 21st day.
Chang Gung University
Other
The Effectiveness of Music Therapy on Fatigue and Laboratory Values in Acute Leukemia Patients Undergoing Chemotherapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00764231
Acute Myeloid Leukemia, Behavior
Toronto, Ontario, Canada
View Trial DetailsNCT03836209
Acute Myeloid Leukemia, Hematologic Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT03374332
Acute Myeloid Leukemia, Disease Attributes
Providence, Rhode Island, United States
View Trial DetailsNCT03455504
Acute Myeloid Leukemia, Hematologic Diseases
Bergamo, Italy
View Trial Details